Quantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7 T and 7 T.
OBJECTIVE
MRI coupled with the intravenous injection of ultrasmall superparamagnetic particles of iron oxides (USPIOs) is a promising tool for the study of neuroinflammation. Quantification of the approximate number of magnetically labelled macrophages may provide an effective and efficient method for monitoring inflammatory cells. The purpose of the present study was to characterise the relaxation properties of macrophages labelled with two types of USPIOs, at 4.7 T and 7 T.


METHODS
USPIO-labelled bone-marrow-derived macrophage phantoms were compared with phantoms of free dispersed USPIOs with the same global iron concentration, using multi-parametric (T1, T2 and T2) quantitative MRI. The same protocol was then evaluated in living mice after intracerebral injection of iron-labelled macrophages vs free iron oxide.


RESULTS
A linear relationship was observed among R1, R2 and R2 values and iron concentration in vitro at 4.7 T and at 7 T. At a given field, T1 and T2 relaxivities of both types of USPIOs decreased following internalisation into macrophages, while T2 relaxivities increased.


CONCLUSIONS
There was fair overall agreement between the theoretical number of injected cells and the number estimated from T2 quantification and in vitro calibration curves, supporting the validity of the present in vitro calibration curves for in vivo investigation.
Brisset
J-C
JC
Université de Lyon, Lyon 1, Lyon 69003, France.
Desestret
V
V
Marcellino
S
S
Devillard
E
E
Chauveau
F
F
Lagarde
F
F
Nataf
S
S
Nighoghossian
N
N
Berthezene
Y
Y
Wiart
M
M
D000818:Animals; D003287:Contrast Media / Q000493:pharmacokinetics; D003911:Dextrans / Q000493:pharmacokinetics*; D005260:Female; D052203:Ferrosoferric Oxide / Q000493:pharmacokinetics*; D007089:Image Enhancement / Q000379:methods; D008264:Macrophages / Q000166:cytology* / Q000378:metabolism*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D051379:Mice; D008810:Mice, Inbred C57BL; D053758:Nanoparticles; D014018:Tissue Distribution; D051598:Whole Body Imaging / Q000379:methods*
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; C097921:ferumoxtran-10; D052203:Ferrosoferric Oxide
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16267-72
12444255
AJNR Am J Neuroradiol. 2006 May;27(5):1000-5
16687532
Eur Radiol. 2005 Jul;15(7):1369-77
15726379
Stroke. 2007 Jan;38(1):131-7
17122417
Adv Drug Deliv Rev. 2006 Dec 1;58(14):1471-504
17116343
Magn Reson Med. 2003 Apr;49(4):646-54
12652535
Radiology. 2007 Aug;244(2):514-23
17562811
Radiology. 2006 Oct;241(1):142-8
16990675
Magn Reson Imaging. 2007 Dec;25(10):1442-8
17614231
Stroke. 2009 May;40(5):1834-41
19286601
Invest Radiol. 2006 Mar;41(3):313-24
16481915
Magn Reson Imaging. 2007 Jul;25(6):748-53
17459640
Radiology. 2005 Aug;236(2):579-87
15972338
Radiology. 2007 Nov;245(2):449-57
17848680
Invest Radiol. 2004 Oct;39(10):619-25
15377941
Stroke. 2007 Feb;38(2):303-7
17170357
Invest Radiol. 2004 Jan;39(1):56-63
14701989
MAGMA. 2008 Mar;21(1-2):63-72
18064501
Eur Radiol. 2006 Mar;16(3):738-45
16308692
Invest Radiol. 2002 Sep;37(9):482-8
12218443
Biomaterials. 2003 Mar;24(6):1001-11
12504522
Radiology. 2005 Jun;235(3):959-67
15845788
Stroke. 2007 Oct;38(10):2733-7
17717318
Magn Reson Med. 2004 Mar;51(3):607-11
15004804
Eur Radiol. 2004 Oct;14(10):1851-8
15249981
Eur Radiol. 2008 Jan;18(1):59-69
17917732
Magn Reson Med. 2004 Jul;52(1):73-9
15236369
Biomaterials. 2007 Mar;28(9):1629-42
17178155
J Magn Reson Imaging. 2006 May;23(5):720-7
16557494
Biomaterials. 2008 Aug;29(22):3161-74
18455232
Brain. 2008 Mar;131(Pt 3):800-7
18245785